Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
Immunophenotypic changes in leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia after treatment with CD19-directed chimeric antigen receptor (CAR)- expressing T cells | Haematologica
Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
CAR T Cell Immunotherapy Beyond Haematological Malignancy
Frontiers | Optimizing the Clinical Impact of CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia: Looking Back While Moving Forward
CAR T cells: Building on the CD19 paradigm - Globerson Levin - 2021 - European Journal of Immunology - Wiley Online Library
TCR+/BCR+ dual-expressing cells and their associated public BCR clonotype are not enriched in type 1 diabetes - ScienceDirect
Percentages of CD4 + IL10 + T cells and CD19 + IL10 + B cells increase,... | Download Scientific Diagram
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
The efficacy and safety of anti-CD19/CD20 chimeric antigen receptor- T cells immunotherapy in relapsed or refractory B-cell malignancies:a meta-analysis | BMC Cancer | Full Text
Frontiers | Automated Manufacture of Autologous CD19 CAR-T Cells for Treatment of Non-hodgkin Lymphoma
Recreation of an antigen-driven germinal center in vitro by providing B cells with phagocytic antigen | Communications Biology
Normal B-cell ranges in infants: A systematic review and meta-analysis - ScienceDirect
Cancers | Free Full-Text | Reliable Flow-Cytometric Approach for Minimal Residual Disease Monitoring in Patients with B-Cell Precursor Acute Lymphoblastic Leukemia after CD19-Targeted Therapy
Immunophenotypic changes of leukemic blasts in children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia who have been treated with blinatumomab | Haematologica
Clinical overview of anti-CD19 BiTE® and ex vivo data from anti-CD33 BiTE® as examples for retargeting T cells in hematologic malignancies - ScienceDirect
JCM | Free Full-Text | Development of CAR T Cell Therapy in Children—A Comprehensive Overview
Cells | Free Full-Text | Flow Cytometric Methods for the Detection of Intracellular Signaling Proteins and Transcription Factors Reveal Heterogeneity in Differentiating Human B Cell Subsets
Characteristics of iKP-19-CAR-T cells and CD19-CAR-T cells.... | Download Scientific Diagram
Frontiers | Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1
Frontiers | Gut Antibody Deficiency in a Mouse Model of CVID Results in Spontaneous Development of a Gluten-Sensitive Enteropathy
